COMMUNIQUÉS West-GlobeNewswire

Precision Therapeutics Gains Extension for Nasdaq Compliance
17/05/2019
MINNEAPOLIS, May 17, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (Nasdaq: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]
Orion Corporation: Managers' transactions - Riikka Westerlund
17/05/2019
ORION CORPORATION MANAGERS' TRANSACTIONS 17 May 2019 at 16.00 EEST Orion Corporation: Managers' transactions - Riikka Westerlund Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]
International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2019
17/05/2019
CARLSBAD, Calif., May 17, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]
Organovo Announces Release Date for Preliminary Fiscal Fourth-Quarter 2019 Financial Results
17/05/2019
SAN DIEGO, May 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Wednesday, May 22, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the Company's preliminary [...]
CB2 Insights Announces Ticker Symbol Change on OTCQB
17/05/2019
TORONTO, May 17, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII) (OTCQB:CBIIF) a leading technology company focused on mainstreaming medical cannabis to the healthcare industry through Real- [...]
Immutep Announces Data from Ongoing TACTI-mel Phase I Clinical Trial in Unresectable or Metastatic Melanoma
17/05/2019
Presented at the World Advanced Therapies & Regenerative Medicine Congress & Expo 2019 SYDNEY, Australia, May 17, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a [...]
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
17/05/2019
WALTHAM Mass. and CRESTWOOD, Ky., May 17, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
AMAG Pharmaceuticals to Host Analyst Day on May 22, 2019 in New York
17/05/2019
WALTHAM, Mass., May 17, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it will host an Analyst Day for the investment community on Wednesday, May 22, 2019 from 8:30 a.m. to 12:00 [...]
Emerald Health Therapeutics lance l'huile de CBD de première qualité SYNC 25 sur le marché récréatif de la Colombie-Britannique
17/05/2019
La SYNC 25 CBD d'Emerald est une huile ultra-pure, donc sans THC et sans fumée, conçue pour répondre à un important besoin sur le marché récréatif de la C.-B. VANCOUVER, Colombie-Britannique, 17 mai 2019 (GLOBE NEWSWIRE [...]
Emerald Health Therapeutics Introduces Unique Premium CBD Oil SYNC 25 to British Columbia Recreational Marketplace
17/05/2019
Emerald’s ultra-pure SYNC 25 CBD oil fills significant need in BC’s recreational marketplace, offering a non-THC, smoke-free alternative VANCOUVER, British Columbia, May 17, 2019 (GLOBE NEWSWIRE) -- Emerald Health [...]
Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla®
17/05/2019
PRINCETON, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration (FDA) the NDA for its [...]
ADMA Biologics Announces Pricing of Public Offering of Common Stock
17/05/2019
RAMSEY, N.J. and BOCA RATON, Fla., May 17, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”) a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company [...]
Natus to Present at William Blair 39th Annual Growth Stock Conference
17/05/2019
PLEASANTON, Calif., May 17, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY) today announced that Drew Davies, Executive Vice President and Chief Financial Officer will present at the William Blair 39 [...]
Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Combination Trial with Eculizumab at The New Era of Aplastic Anemia and PNH Meeting
17/05/2019
- ACH-4471 increased hemoglobin and nearly eliminated the need for transfusions in patients with PNH being treated with C5 inhibitor, eculizumab - BLUE BELL, Pa., May 17, 2019 (GLOBE NEWSWIRE) -- Achillion [...]
Pulmocide presents clinical update from promising antifungal program at 2019 Respiratory Innovation Summit
17/05/2019
Pulmocide presents clinical update from promising antifungal program at 2019 Respiratory Innovation Summit London, UK; 17 May 2019 – Pulmocide Ltd, which is developing first-in-class inhaled anti-infectives for targeted [...]
Arch Biopartners Arranges Convertible Note Financing
17/05/2019
TORONTO, May 17, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced it has arranged a non-brokered, unsecured convertible note (“Note”) financing [...]
Mesoblast to Present at 2019 RBC Capital Markets Global Healthcare Conference
17/05/2019
NEW YORK and MELBOURNE, Australia, May 17, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO; ASX: MSB), global leader in cellular medicines for inflammatory diseases, today announced an upcoming corporate [...]
Terveystalo's network of occupational health services to expand: Terveystalo to acquire Työsyke Oy in Kanta-Häme
17/05/2019
Press release 17 May 2019 The owners of Työsyke Oy, the city of Hämeenlinna, the municipality of Kanta-Häme Hospital District, the city of Riihimäki, the municipality of the Riihimäki Region Health Center, the [...]
Biocartis Group NV: Disclosure of a transparency notification
17/05/2019
PRESS RELEASE : REGULATED INFORMATION 17 May 2019, 07:00 CEST Disclosure of a transparency notification Mechelen, Belgium, 17 May 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular [...]

Pages